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 Abstract: 
Background: Screening participants with abnormal faecal occult blood test 
(FOBt) results who do not attend further testing are at high-risk of colorectal 
cancer (CRC), yet little is known about their reasons for non-attendance.  
Methods: We conducted a medical record review of 170 patients from two 
[BLINDED SCREENING PROGRAMME] screening centres who had 
abnormal gFOBt screening tests between November 2011 and April 2013 and 
did not undergo colonoscopy. Using information contained in patient records, 
we coded and categorised reasons for non-attendance. 
Results: Of the 170 patients, 82 were eligible for review, of which 66 had at 
least one recorded reason for lack of colonoscopy follow-up. Reasons fell into 
seven main categories: (i) other commitments, (ii) unwillingness to have the 
test, (iii) a feeling that the FOBt result was a false-positive, (iv) another health 
issue taking priority, (v) failing to complete bowel preparation, (vi) practical 
barriers (e.g. lack of transport), and (vii) having had or planning colonoscopy 
elsewhere.  The most common single reasons were unwillingness to have a 
colonoscopy and being away.   
Conclusions: We identify a range of apparent reasons for colonoscopy non-
attendance after a positive FOBT screening. Education regarding the 
interpretation of gFOBt findings, offer of alternative confirmatory test options 
and flexibility in the timing or location of subsequent testing might decrease 
non-attendance of diagnostic testing following positive FOBt. 
Introduction 
There are many methods of screening for colorectal cancer (CRC), although 
one common approach is periodic faecal occult blood testing (FOBt)1,2. Meta-
analysis of randomised trials demonstrates that guaiac-based FOBt reduces 
CRC-related mortality by approximately 16%3. Such mortality reductions 
require further colonic testing after a positive FOBt to diagnose CRC and treat 
smaller cancers or adenomas by endoscopic excision. Maximising screening 
completion (i.e. colonoscopy) is crucial for these patients, because up to 10% 
will have CRC at their first screen4. 
 
Randomised trials of FOBt screening reported non-completion rates of 7-17% 
after a positive FOBt result5-8. Similarly, analysis of the UK CRC screening 
pilot9 and during national roll-out4 found non-completion rates of 15-18% after 
positive FOBt. Comparable French data report a 12% rate10; in Ontario, 
Canada, the figure is approximately 1 in 311. Therefore, depending on 
programme structure, 10-33% of FOBt-positive screenees do not undergo 
confirmatory testing. Certain patient groups are at higher risk of non-
completion; for example, those with lower socio-economic status12, 13, or 
physical/psychological co-morbidity14. These “epidemiological signals” 
suggest there may be missed diagnostic opportunities15 in FOBt-based CRC 
screening at the time of colonoscopy – which might be targets to improve 
uptake. 
 
In general terms, missed diagnostic opportunities may be due to 
organizational factors (e.g. insufficient endoscopy resource, poor referral 
guidelines) or patient factors (e.g. cognitive, emotional or physical barriers). 
For example, physicians commonly fail to act on positive FOBt results16, 
either because they never reviewed the result or chose to repeat the FOBt, 
thereby going against good practice guidelines17,18. However, these individual 
physician-related and organizational factors are of less relevance to 
population screening programmes in which endoscopy capacity is assured, 
referral guidelines are established, and the administrative burden is often 
centralized4,10,11. Conversely, there are few data regarding patient-specific 
factors underpinning non-completion in this setting. Lower socio-economic 
status and physical/psychological co-morbidity are associated with higher 
rates of non-completion, but we do not know how these risk factors translate 
to individual decision-making.   
 
Thus, FOBt-positive individuals who do not attend for colonoscopy represent 
a large, high-risk group. There are few patient-level data on why such non-
attendance occurs. Therefore, we investigated this in a population-based 
screening programme with a centralised call-recall system via retrospective 
review of detailed screening records.  
 
Materials and Methods 
This study was conducted within the [BLINDED SCREENING PROGRAMME, 
ScP] and was approved by the [ScP] Research Committee. Following HRA 
guidance, ethical permission was not required for retrospective review of 
anonymised, routinely-acquired data. 
Study Population  
The [ScP] uses biennial FOBt for individuals aged 60-74 years4. 
Administration and analysis of FOBt kits is coordinated by 5 regional 
laboratories. After a positive result, clinical review and colonic testing are 
conducted at a local “screening centre”. Clinical review is led by a trained 
Specialist Screening Practitioner (SSP). The screening pathway is shown in 
Figure 1. This study was conducted within two of the 62 screening centres. 
These centres were selected because they (a) had resources available to 
support the study, (b) had pre-existing research collaborations with the study 
team and (c) were located within a single Hub, simplifying information 
governance. 
 
Individuals were eligible for inclusion if they had a positive FOBt result from 
November 2011-April 2013 but had not attended a SSP Clinic (to assess 
fitness for colonic testing and seek informed consent) or an appointment for 
colonic testing. These individuals were identified by using the [ScP] in-house 
database by the Hub Director [INITIALS BLINDED] who extracted episode 
notes (including free text entries by screening centre staff) for the researchers 
conducting the medical record review.   
 
Routine [ScP] practice is for two appointment letters to be sent for the SSP 
clinic.  If no contact has been made after this, the screenee is considered a 
non-attender and the screening episode is closed. Non-participation at 
colonoscopy is followed by a telephone call (and a letter if non-contactable), 
inviting the screenee to re-arrange the appointment; non-response by 14 days 
precipitates episode closure. 
 
Data extraction 
We undertook a detailed medical records review of eligible participants to 
obtain information about non-attendance. The programme records system is a 
structured Oracle database (Oracle Corporation, Redwood, CA, USA). Each 
event within a given screening episode (whether a test result, care decision, 
or clinical interaction, including telephone consultations) is recorded. Free text 
entries are encouraged and such notes are kept meticulously by SSPs. These 
clinical notes constitute a detailed and valuable resource for monitoring and 
assessing patient behaviour.   
 
To complete the screening records review, the Screening Hub Director 
[INITIALS BLINDED] reviewed the clinical entries of all eligible patients and 
extracted the following; (i) screenee age and sex; (ii) point of departure from 
the screening pathway (i.e. non-attendance at the SSP clinic vs colonoscopy); 
(iii) previous CRC screening history; (iv) subsequent CRC screening history; 
and (v) free-text entries recording reasons for non-attendance. Free text 
entries were made by Screening Centre Staff and summarised conversation 
with the patient (or their representative) and screening centre staff (either at 
the SSP clinic or by telephone). To satisfy research governance permissions, 
the Hub Director excluded participants who had died, left the 
country/screening centre or refused permission for further contact by the 
screening programme. 
 Analysis 
These free-text entries were coded by [BLINDED], a psychology researcher; 
and [BLINDED], a medical practitioner with academic interest in CRC 
screening. Data were analysed based on established qualitative research 
methodology19, 20. Initially, each researcher independently reviewed and 
interpreted the free-text data and identified broad categories emerging as 
reasons for non-attendance (e.g. “unwilling to have test”). Patients were then 
coded into all categories that were considered to apply to them. The two 
researchers then harmonised categories and coding by face-to-face 
discussion. Category names were discussed to determine whether they could 
be meaningfully merged with others, renamed or separated under distinct 
headings, or grouped under a broader category heading. The independently-
derived codes for each patient were also discussed and any disagreements 
were resolved in consensus, arbitrated by a third researcher [BLINDED, a 
psychology researcher] who was blinded to the originally-assigned codes to 
avoid biasing their decision.  
 
Finally, for each individual subject, the single most important reason for non-
attendance was recorded, as judged subjectively in consensus by the raters 
based on information in the medical records. Data were summarised with 
descriptive statistics. 
 
Results 
Characteristics of study population 
During the study period, 177,863 individuals were invited for screening across 
the two centres. 87,664 completed FOBt screening (49.3%) and 2,404 had a 
positive result (2.7% of those returning a test kit). Records review identified 
170 individuals (7.1% of those with a positive result) who ultimately did not 
undergo colonoscopy prior to screening episode closure (Figure 1 shows 
routes to episode closure). Of these, 88 individuals (51.8% of all non-
attenders) were excluded by the screening hub director prior to data 
extraction because they had died, left the country, moved to another part of 
the country or had requested removal of their contact details from the 
screening programme database, leaving 82 cases for further analysis. No 
further data were available for the 88 excluded individuals. 
 
Included individuals had a median age of 64.5 years (interquartile range:62.2-
69.2 years) and there was an approximately equal gender split (42 females, 
40 males). Patients often had a previous history of screening non-adherence: 
36 kits had been returned from the 72 previous episodes for which data were 
available, giving an overall previous gFOBt uptake of 50.0%. About half of all 
non-attenders did not attend the SSP clinic appointment (38/82,46.3%) and 
half attended clinic but not colonoscopy (44/82,53.7%).  
 
Patients frequently made repeated telephone contact with screening services, 
despite ultimately not attending. The median number of times a non-attending 
screenee was in contact with the screening centre was 2 (IQR:1-4). 
Furthermore, family members often also telephoned screening centres on the 
behalf of the patient; this occurred for 15 of the 82 individuals (18.3%). Most 
commonly, this was to explain non-attendance. 8 patients (or family members) 
requested an interpreter (9.8%).  
 
39 individuals had been sent a further FOBt kit by the time of data analysis 
(i.e. had entered their next biennial round of FOBt screening). Of these, only 
17 (43.6%) completed this further round of screening.  
 
Reasons for non-participation at screening colonoscopy 
Of the 82 patients, in 66 cases (80.5%) it was possible to extract at least one 
reason for non-participation from the clinical records. 16 individuals had no 
relevant information recorded. The remaining 66 individuals had a total of 93 
recorded reasons for non-participation, summarised in Table 1.  
 
Most patients had a single recorded reason for non-participation 
(43/66,65.2%), 18 individuals (27.3%) had 2 recorded reasons and 5 
individuals (7.6%) had 3 recorded reasons. Explanations for non-participation 
fell into seven broad categories: unwillingness to have the test (28/93 
reasons,30.1%), other commitments (21/93 stated reasons,22.6%), belief that 
the FOBt result was a false-positive (16/93 reasons,17.2%), another health 
issue taking priority (14/93 reasons,15.0%), already having investigation 
planned elsewhere (7/93 reasons,7.5%); practical barriers (5/93 
reasons,5.4%) and patient errors in bowel preparation / dietary restriction 
(2/93 reasons,2.2%) (see detailed breakdown of reason categories in Table 
1). 
 
Reasons for non-participation were largely similar for either SSP clinic or 
colonoscopy non-participation, with the exception that SSP clinic non-
attenders were more likely to have already arranged colonoscopy outside the 
programme (SSP non-attenders:5/23 total reasons for non-attendance, 
21.7%; Colonoscopy non-participants: 2/70 total reasons,2.9%, p=0.0079; 
Table 1).  
  
When considering only an individual’s most important reason for non-
participation, similar patterns were demonstrated. 17 of 66 individuals had 
other commitments (25.8%), 16/66 (24.2%) were unwilling to undergo the test, 
13/66 (19.7%) believed the FOBt result was a false-positive, 12/66 (18.2%) 
patients had another health issue taking priority, 7/66 (10.6%) were planning 
treatment elsewhere and 1/66 (1.5%) had a practical barrier (e.g. distance to 
travel, issues with fasting). 
 
Author interpretations of free-text data entries  
During interpretation, we noted that many stated reasons for non-attendance 
were temporary rather than permanent. Examples included short-term 
illnesses (such as a cold, fever or a problem with medication) or brief trips 
away, neither of which would preclude colonoscopy at a later date. In these 
cases, patients may have subsequently forgotten about their appointment. 
However, some individuals later refused colonoscopy even after a telephone 
reminder (e.g. “patient said she could not come because she's got a bad cold. 
She was asked if she wanted to rebook. She said she will call when she feels 
better…[weeks later]…SSP phoned patient to rebook but she does not want 
to proceed”; female, 71 years). Another common theme was denial and 
disbelief that the FOBt result might indicate CRC, and instead must have 
been a false-positive (e.g. “Patient opted out – insists results were positive 
due to a bloody tissue she placed on faeces”; female,69 years; “Patient has 
piles and is convinced that the bleeding was just due to that”; female,69 
years).  
Discussion 
In this study, we retrospectively reviewed medical records of patients who had 
not completed colonoscopy despite a positive screening FOBt result. We 
grouped reasons for non-attendance into broad categories; the largest of 
which were unwillingness to have colonoscopy, other commitments, the belief 
that the FOBt test result was a false-positive, or other health issues taking 
priority.  
 
Previous research regarding non-attendance for colonoscopy has often 
focused on its use as a first-line test21. Although this provides information 
regarding colonoscopy-specific barriers, it does not necessarily apply to a 
screening programme based on FOBt (or Fecal Immunochemical Testing, 
FIT), in which patients testing positive are at higher risk of CRC22, 23. 
Considering FOBt-positive individuals specifically, Shields et al24 reported on 
patients in a US municipal opportunistic screening programme: Those with a 
positive family history of CRC, greater worry regarding cancer or with a more 
strongly positive FOBt result were more likely to undergo colonoscopy. Zheng 
et al25 found that patients who perceived fewer barriers to screening, greater 
benefits of screening and had greater knowledge of CRC risk factors reported 
higher intention to complete screening. More recent data from the Ontario 
FOBt-based screening programme found that participants with recent prior 
colonoscopy, hospital admission or having repeat FOBt were less likely to 
complete colonic testing11. Ferrat et al12 found low socio-economic status was 
associated with non-completion, as were receiving the FOBt kit via post rather 
than from a General Practitioner, and inadequate information regarding 
colonoscopy. Partin et al14 found that older patients, those with limited life 
expectancy, and dual diagnosis of psychiatric disorder/substance abuse had 
higher non-completion rates. 
 
We found that the test itself (colonoscopy) constituted a major barrier to 
screening completion after positive FOBt. This concurs with recent evidence 
from a vignette-based study in which 11% of respondents would have 
declined colonoscopy even if they had symptoms indicating a 10% risk of 
CRC (similar to after a postive FOBt result)26. An appreciable proportion of 
patients clearly find colonoscopy unappealing, even in the face of a high risk 
of CRC. Some of these concerns may be alleviated by the offer of alternative 
tests (e.g. CT colonography), which might be perceived as more acceptable. 
Data from a Dutch randomised trial suggested that non-attendance at 
colonoscopy was more likely due to concerns regarding the test, whereas 
non-attendance at CT colonography was more likely underpinned by lack of 
time27. US data suggest that non-attenders at colonoscopy would accept an 
offer of CT colonography28, and a small randomised study from Italy found 
that FOBt-positive patients who declined colonoscopy were more likely to 
attend when offered CTC than those who were re-offered colonoscopy29. 
 
However, altering the test used will not always address fundamental reasons 
for non-attendance. For example, 16 patients felt there were alternative 
explanations for their positive FOBt result (including haemorrhoids) or that the 
result was somehow “incorrect” (e.g. normal previous colonoscopy). Offering 
an alternative test will not address such misconceptions. Instead, it is 
important to improve awareness of the principles of CRC screening, 
particularly with regard to previous colonoscopy (i.e. that a previous normal 
examination does not always obviate subsequent disease). 
 
Most of the documented reasons for non-completion could have potentially 
been overcome.  For example, temporary fasting or incorrect use of bowel 
preparation could be resolved by rescheduling. Similarly, while some of the 
other health issues taking priority were serious, others were not (e.g. 
temporary medication problems, having a fever or the common cold), and 
should not prevent colonoscopy at a later date. It is possible that these stated 
reasons masked true underlying causes. Previous studies have described that 
patients often present superficial explanations for non-attendance that 
obscure genuine concerns, such as fear of being diagnosed with cancer30. 
Furthermore, for patients who may already be ambivalent to completing 
screening, an ostensibly small barrier may become relatively more important 
(since that individual may feel there is relatively little to gain by completing 
screening in any case). 
 
Since many patients in their interactions with the screening centre cited 
surmountable barriers, it is worth considering how uptake of diagnostic follow-
up might be increased. The diverse range of stated reasons for non-
attendance means that any single untargeted intervention is unlikely to be 
successful. Some possible approaches to address the specific barriers we 
uncovered are shown in Table 2.  A “hybrid” approach, with primary care 
endorsement of a centrally-administered screening process might unify the 
advantages of both strategies. Such primary care endorsement has been 
shown to boost FOBt uptake31 and so it is plausible that it might also be 
effective for colonoscopy non-attenders. Direct contact with health 
professionals who can present the case for screening, support informed 
decision-making, and assist people through the process, may be essential for 
patients who do not engage initially. US research with “hard-to-reach” groups 
suggests that so-called “patient navigation” can achieve greater effects 
compared with those reported for more conventional low-intensity 
interventions32, although a randomised trial of patient navigation in a group of 
FOBt-positive individuals who did not complete colonic testing failed to show a 
statistically-significant increase in attendance33. 
 
The main strength of this study was the fact that we were able to identify 
reasons for non-attendance among a particularly difficult-to-access group of 
individuals, often neglected by prior research. Furthermore, these are patient-
triggered case notes, meaning that the contents likely align with patients’ own 
beliefs. The fact that we found a much smaller proportion of patients who did 
not complete colonoscopy (7.1%) than has previously been reported, both in 
the UK4 and internationally10,11,30 is likely due to different methods of data 
extraction and “filtering” of our dataset by the screening Hub Director to 
ensure patient confidentiality. It is possible that we have not captured some 
important reasons for non-attendance. 
 
Our study is also limited because we were required to use retrospective 
reviews of medical records to overcome the difficulties of contacting and 
interviewing non-adherent patients. Although detailed, it is possible that these 
medical records do not capture all relevant reasons, and some richness of the 
dataset will no doubt be lost. Furthermore, the fact that they have been 
entered by screening staff (rather than patients themselves) means there is a 
risk of failure to accurately capture the patients’ original thoughts or intentions. 
Although one-to-one interviews are an intuitively appealing alternative, we 
originally invited patients for a telephone interview to explore their reasons for 
non-attendance, and received only a 3% response rate – such interviews 
would be neither representative nor practical. Engagement of non-attenders is 
clearly extremely challenging, although intense recruitment facilitated via 
primary care might be possible. Additionally, there was a degree of 
subjectivity in our assessment and coding process, although we reduced this 
by using two independent coders and resolving disagreements with a third 
arbitrator. Our relatively small sample size means the estimated prevalence of 
each barrier to attendance carries some uncertainty. This could be addressed 
by a larger data extraction in the future, allowing more confident estimates of 
the importance of each of our major categories of reasons for non-attendance.  
Finally, the screening centres participating in this study are both urban, with 
relatively higher socio-economic deprivation and ethnic diversity than the 
national average. 
 
In summary, the most frequently-stated reasons for non-completion of 
colonoscopy in FOBt-positive patients were unwillingness to have the test, the 
perception that their FOBt result was a false positive, or other commitments 
and health issues taking priority. These individuals had low adherence to 
subsequent FOBt screening, meaning they remain a difficult-to-screen group. 
Education regarding the nature of FOBt screening and offering alternative 
tests with flexible scheduling at a range of locations might address some of 
these concerns. 
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